The funding round was led by 24Haymarket and will support product development and customer support.
"We are proud of what we’ve achieved so far in just a few years – we’re already the market leader. We have partnered with a variety of NHS trusts and care providers, including supporting Milton Keynes University Hospitals NHS Trust to become the first trust to roll out the new NHS Learn from Patient Safety Events. This will record patient incidents so the data can be used to improve patient safety across the whole healthcare industry. Our platform frees up healthcare providers to focus on caring, not paperwork – enabling a proactive approach to patient and resident care."
The Cambridge-based biotechnology startup has closed a £2.4m round backed by investors from the UK and US.
"We welcome our new investors and thank our existing investors for their continuing confidence in Spirea. With our novel approach to building ADC therapeutics, we aim to radically improve the treatment options for patients with hard-to-treat cancers. Having shown the flexibility and strength of our technology, we look forward to the next exciting stage in the development of Spirea’s ADC pipeline and to building significant strategic partnerships."
The Series C financing was led by Advent Life Sciences with backing from several new and existing institutional investors to accelerate product development and scale operations.
"We are delighted to partner with Proximie and a world class group of investors as the company expands its global footprint and product capabilities. The company is a perfect fit for our ethos of backing best-in-class innovative life sciences businesses that have the capability to positively impact human health and healthcare delivery in paradigm changing ways."
The cannabis distributor secured £7.4m alongside a string of international acquisitions.
"Sana’s latest fundraising round and rapid growth clearly shows the appetite for a well-run, regulated legal cannabis market in Europe. With estimates of a million people in the UK potentially buying medicinal cannabis from the black market due to financial and legal barriers, accessible solutions like Sana are desperately needed."
Jenson Funding Partners backed the London-based online dermatology service to support platform development and service expansion.
"Without the ability to quickly and easily see a dermatologist, patients often go for months or even years without receiving proper treatment for acne, which can have a huge impact on emotional and mental health as well as the risk of causing permanent scarring. Typically, their treatment journey begins with online research, with resources varying in reliability, before trialling over-the-counter skincare products, which are not sufficient in a lot of cases,"
.png)